Cancer Research Meeting Calendar Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, C.
Right arrow Articles by Lu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, C.
Right arrow Articles by Lu, J.
[Cancer Research 61, 3062-3070, April 1, 2001]
© 2001 American Association for Cancer Research

Experimental Therapeutics

Caspases as Key Executors of Methyl Selenium-induced Apoptosis (Anoikis) of DU-145 Prostate Cancer Cells1

Cheng Jiang, Zaisen Wang, Howard Ganther and Junxuan Lu2

AMC Cancer Research Center, Denver, Colorado 80214 [C. J., Z. W., J. L.], and University of Wisconsin-Madison, Madison, Wisconsin 53706 [H. G.]

Apoptosis induction may be a mechanism mediating the anticancer activity of selenium. Our earlier work indicated that distinct cell death pathways are likely involved in apoptosis induced by the CH3SeH and the hydrogen selenide pools of selenium metabolites. To explore the role of caspases in cancer cell apoptosis induced by selenium, we examined the involvement of these molecules in the death of the DU-145 human prostate carcinoma cells induced by methylseleninic acid (MSeA), a novel penultimate precursor of the putative critical anticancer metabolite CH3SeH. Sodium selenite, a representative of the genotoxic selenium pool, was used as a reference for comparison. The results show that MSeA-induced apoptosis was accompanied by the activation of multiple caspases (caspase-3, -7, -8, and -9), mitochondrial release of cytochrome c (CC), poly(ADP-ribose) polymerase (PARP) cleavage, and DNA fragmentation. In contrast, selenite-induced apoptotic DNA fragmentation was observed in the absence of these changes, but was associated with the phosphorylation of c-Jun-NH2-terminal kinase 1/2 and p38 mitogen-activated protein kinase/stress-activated protein kinase 2. A general caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp-(OMe) fluoromethyl ketone, blocked MSeA-induced cleavage of procaspases and PARP, CC release, and DNA nucleosomal fragmentation, but did not prevent cell detachment. Furthermore, PARP cleavage and caspase activation were confined exclusively to detached cells, indicating that MSeA induction of cell detachment was a prerequisite for caspase activation and apoptosis execution. This process therefore resembled "anoikis," a special mode of apoptosis induction in which adherent cells lose contact with the extracellular matrix. Additional experiments with irreversible caspase inhibitors show that MSeA-induced anoikis involved caspase-3- and -7-mediated PARP cleavage that was initiated by caspase-8 and probably amplified through CC-caspase-9 activation and a feedback activation loop from caspase-3. Taken together, the data support a methyl selenium-specific induction of DU-145 cell apoptosis that involves cell detachment as a prerequisite (anoikis) and is executed principally through caspase-8 activation and its cross-talk with multiple caspases.




This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
H. Hu, Y. Chai, L. Wang, J. Zhang, H. J. Lee, S.-H. Kim, and J. Lu
Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells
Mol. Cancer Ther., October 1, 2009; 8(10): 2833 - 2843.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
U. Gundimeda, J. E. Schiffman, S. N. Gottlieb, B. I. Roth, and R. Gopalakrishna
Negation of the cancer-preventive actions of selenium by over-expression of protein kinase C{varepsilon} and selenoprotein thioredoxin reductase
Carcinogenesis, September 1, 2009; 30(9): 1553 - 1561.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
H. Zeng, M. Wu, and J. H. Botnen
Methylselenol, a Selenium Metabolite, Induces Cell Cycle Arrest in G1 Phase and Apoptosis via the Extracellular-Regulated Kinase 1/2 Pathway and Other Cancer Signaling Genes
J. Nutr., September 1, 2009; 139(9): 1613 - 1618.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Hu, J. Zhang, H. J. Lee, S.-H. Kim, and J. Lu
Penta-O-galloyl-beta-D-glucose induces S- and G1-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1
Carcinogenesis, May 1, 2009; 30(5): 818 - 823.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
L. Wang, M. J.L. Bonorden, G.-x. Li, H.-J. Lee, H. Hu, Y. Zhang, J. D. Liao, M. P. Cleary, and J. Lu
Methyl-Selenium Compounds Inhibit Prostate Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model with Survival Benefit
Cancer Prevention Research, May 1, 2009; 2(5): 484 - 495.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
W. Jiang, C. Jiang, H. Pei, L. Wang, J. Zhang, H. Hu, and J. Lu
In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes
Mol. Cancer Ther., March 1, 2009; 8(3): 682 - 691.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. M. Lippman, E. A. Klein, P. J. Goodman, M. S. Lucia, I. M. Thompson, L. G. Ford, H. L. Parnes, L. M. Minasian, J. M. Gaziano, J. A. Hartline, et al.
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
JAMA, January 7, 2009; 301(1): 39 - 51.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
U. Gundimeda, J. E. Schiffman, D. Chhabra, J. Wong, A. Wu, and R. Gopalakrishna
Locally Generated Methylseleninic Acid Induces Specific Inactivation of Protein Kinase C Isoenzymes: RELEVANCE TO SELENIUM-INDUCED APOPTOSIS IN PROSTATE CANCER CELLS
J. Biol. Chem., December 12, 2008; 283(50): 34519 - 34531.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
H. Hu, H.-J. Lee, C. Jiang, J. Zhang, L. Wang, Y. Zhao, Q. Xiang, E.-O. Lee, S.-H. Kim, and J. Lu
Penta-1,2,3,4,6-O-galloyl-{beta}-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo
Mol. Cancer Ther., September 1, 2008; 7(9): 2681 - 2691.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Z. Li, L. Carrier, and B. G. Rowan
Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells
Mol. Cancer Ther., September 1, 2008; 7(9): 3056 - 3063.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G.-x. Li, H.-J. Lee, Z. Wang, H. Hu, J. D. Liao, J. C. Watts, G. F. Combs Jr, and J. Lu
Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite
Carcinogenesis, May 1, 2008; 29(5): 1005 - 1012.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Hu, G.-x. Li, L. Wang, J. Watts, G. F. Combs Jr., and J. Lu
Methylseleninic Acid Enhances Taxane Drug Efficacy against Human Prostate Cancer and Down-Regulates Antiapoptotic Proteins Bcl-XL and Survivin
Clin. Cancer Res., February 15, 2008; 14(4): 1150 - 1158.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
S. Liu, H. Zhang, L. Zhu, L. Zhao, and Y. Dong
Kruppel-Like Factor 4 Is a Novel Mediator of Selenium in Growth Inhibition
Mol. Cancer Res., February 1, 2008; 6(2): 306 - 313.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
I. A. Mawji, C. D. Simpson, R. Hurren, M. Gronda, M. A. Williams, J. Filmus, J. Jonkman, R. S. Da Costa, B. C. Wilson, M. P. Thomas, et al.
Critical Role for Fas-Associated Death Domain-Like Interleukin-1-Converting Enzyme-Like Inhibitory Protein in Anoikis Resistance and Distant Tumor Formation
J Natl Cancer Inst, May 16, 2007; 99(10): 811 - 822.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
U. Peters, C. B Foster, N. Chatterjee, A. Schatzkin, D. Reding, G. L Andriole, E D. Crawford, S. Sturup, S. J Chanock, and R. B Hayes
Serum selenium and risk of prostate cancer--a nested case-control study
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 209 - 217.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
R. G. Azrak, C. L. Frank, X. Ling, H. K. Slocum, F. Li, B. A. Foster, and Y. M. Rustum
The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.
Mol. Cancer Ther., October 1, 2006; 5(10): 2540 - 2548.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
H. Hu, C. Jiang, T. Schuster, G.-X. Li, P. T. Daniel, and J. Lu
Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway.
Mol. Cancer Ther., July 1, 2006; 5(7): 1873 - 1882.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. El-Bayoumy, A. Das, B. Narayanan, N. Narayanan, E. S. Fiala, D. Desai, C. V. Rao, S. Amin, and R. Sinha
Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer
Carcinogenesis, July 1, 2006; 27(7): 1369 - 1376.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. Veluri, R. P. Singh, Z. Liu, J. A. Thompson, R. Agarwal, and C. Agarwal
Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells
Carcinogenesis, July 1, 2006; 27(7): 1445 - 1453.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Zhao, N. Xiang, F. E. Domann, and W. Zhong
Expression of p53 Enhances Selenite-Induced Superoxide Production and Apoptosis in Human Prostate Cancer Cells
Cancer Res., February 15, 2006; 66(4): 2296 - 2304.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Jiang, H.-J. Lee, G.-x. Li, J. Guo, B. Malewicz, Y. Zhao, E.-O. Lee, H.-J. Lee, J.-H. Lee, M.-S. Kim, et al.
Potent Antiandrogen and Androgen Receptor Activities of an Angelica gigas-Containing Herbal Formulation: Identification of Decursin as a Novel and Active Compound with Implications for Prevention and Treatment of Prostate Cancer
Cancer Res., January 1, 2006; 66(1): 453 - 463.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Wu, H. Zhang, Y. Dong, Y.-M. Park, and C. Ip
Endoplasmic Reticulum Stress Signal Mediators Are Targets of Selenium Action
Cancer Res., October 1, 2005; 65(19): 9073 - 9079.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Hu, C. Jiang, G. Li, and J. Lu
PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells
Carcinogenesis, August 1, 2005; 26(8): 1374 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Dong, H. Zhang, A. C. Gao, J. R. Marshall, and C. Ip
Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers
Mol. Cancer Ther., July 1, 2005; 4(7): 1047 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Hu, C. Jiang, C. Ip, Y. M. Rustum, and J. Lu
Methylseleninic Acid Potentiates Apoptosis Induced by Chemotherapeutic Drugs in Androgen-Independent Prostate Cancer Cells
Clin. Cancer Res., March 15, 2005; 11(6): 2379 - 2388.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Yim, R. P. Singh, C. Agarwal, S. Lee, H. Chi, and R. Agarwal
A Novel Anticancer Agent, Decursin, Induces G1 Arrest and Apoptosis in Human Prostate Carcinoma Cells
Cancer Res., February 1, 2005; 65(3): 1035 - 1044.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L. Bjorkhem-Bergman, U.-B. Torndal, S. Eken, C. Nystrom, A. Capitanio, E. H. Larsen, M. Bjornstedt, and L. C. Eriksson
Selenium prevents tumor development in a rat model for chemical carcinogenesis
Carcinogenesis, January 1, 2005; 26(1): 125 - 131.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. J. K. Williamson, B. C. Dibling, J. R. Boyne, P. Selby, and S. A. Burchill
Basic Fibroblast Growth Factor-induced Cell Death Is Effected through Sustained Activation of p38MAPK and Up-regulation of the Death Receptor p75NTR
J. Biol. Chem., November 12, 2004; 279(46): 47912 - 47928.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. Jiang, H. Hu, B. Malewicz, Z. Wang, and J. Lu
Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells
Mol. Cancer Ther., July 1, 2004; 3(7): 877 - 884.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
P. R. Taylor, H. L. Parnes, and S. M. Lippman
Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis
J Natl Cancer Inst, May 5, 2004; 96(9): 645 - 647.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S.-Y. Sun, N. Hail Jr, and R. Lotan
Apoptosis as a Novel Target for Cancer Chemoprevention
J Natl Cancer Inst, May 5, 2004; 96(9): 662 - 672.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. D. Cho, C. Jiang, B. Malewicz, Y. Dong, C. Y.F. Young, K.-S. Kang, Y.-S. Lee, C. Ip, and J. Lu
Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription
Mol. Cancer Ther., May 1, 2004; 3(5): 605 - 612.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
N. V. Gopee, V. J. Johnson, and R. P. Sharma
Sodium Selenite-Induced Apoptosis in Murine B-Lymphoma Cells Is Associated with Inhibition of Protein Kinase C-{delta}, Nuclear Factor {kappa}B, and Inhibitor of Apoptosis Protein
Toxicol. Sci., April 1, 2004; 78(2): 204 - 214.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
H. Zhao, M. L. Whitfield, T. Xu, D. Botstein, and J. D. Brooks
Diverse Effects of Methylseleninic Acid on the Transcriptional Program of Human Prostate Cancer Cells
Mol. Biol. Cell, February 1, 2004; 15(2): 506 - 519.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Dong, S. O. Lee, H. Zhang, J. Marshall, A. C. Gao, and C. Ip
Prostate Specific Antigen Expression Is Down-Regulated by Selenium through Disruption of Androgen Receptor Signaling
Cancer Res., January 1, 2004; 64(1): 19 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Zu and C. Ip
Synergy between Selenium and Vitamin E in Apoptosis Induction Is Associated with Activation of Distinctive Initiator Caspases in Human Prostate Cancer Cells
Cancer Res., October 15, 2003; 63(20): 6988 - 6995.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
D. J. Waters, S. Shen, D. M. Cooley, D. G. Bostwick, J. Qian, G. F. Combs Jr., L. T. Glickman, C. Oteham, D. Schlittler, and J. S. Morris
Effects of Dietary Selenium Supplementation on DNA Damage and Apoptosis in Canine Prostate
J Natl Cancer Inst, February 5, 2003; 95(3): 237 - 241.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Dong, H. Zhang, L. Hawthorn, H. E. Ganther, and C. Ip
Delineation of the Molecular Basis for Selenium-induced Growth Arrest in Human Prostate Cancer Cells by Oligonucleotide Array
Cancer Res., January 1, 2003; 63(1): 52 - 59.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. Agarwal, R. P. Singh, and R. Agarwal
Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release
Carcinogenesis, November 1, 2002; 23(11): 1869 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. Jiang, Z. Wang, H. Ganther, and J. Lu
Distinct Effects of Methylseleninic Acid versus Selenite on Apoptosis, Cell Cycle, and Protein Kinase Pathways in DU145 Human Prostate Cancer Cells
Mol. Cancer Ther., October 1, 2002; 1(12): 1059 - 1066.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. V. Gasparian, Y. J. Yao, J. Lu, A. Y. Yemelyanov, L. A. Lyakh, T. J. Slaga, and I. V. Budunova
Selenium Compounds Inhibit I{kappa}B Kinase (IKK) and Nuclear Factor-{kappa}B (NF-{kappa}B) in Prostate Cancer Cells
Mol. Cancer Ther., October 1, 2002; 1(12): 1079 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
U. Steidl, R. Kronenwett, U.-P. Rohr, R. Fenk, S. Kliszewski, C. Maercker, P. Neubert, M. Aivado, J. Koch, O. Modlich, et al.
Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells
Blood, March 15, 2002; 99(6): 2037 - 2044.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Wang, C. Jiang, H. Ganther, and J. Lu
Antimitogenic and Proapoptotic Activities of Methylseleninic Acid in Vascular Endothelial Cells and Associated Effects on PI3K-AKT, ERK, JNK and p38 MAPK Signaling
Cancer Res., October 1, 2001; 61(19): 7171 - 7178.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.